Point-of-care sexually transmitted infection diagnostics: Proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting

Anthony D. Cristillo, Claire C. Bristow, Rosanna Peeling, Barbara Van Der Pol, Sasha Herbst De Cortina, Ivan K. Dimov, Nitika Pant Pai, Dong Jin Shin, Ricky Y.T. Chiu, Catherine Klapperich, Purnima Madhivanan, Sheldon R. Morris, Jeffrey D. Klausner

Research output: Contribution to journalArticlepeer-review

32 Scopus citations

Abstract

The goal of the point-of-care (POC) sexually transmitted infection (STI) Diagnostics meeting was to review the state-of-the-art research and develop recommendations for the use of POC STI diagnostics. Experts from academia, government, nonprofit, and industry discussed POC diagnostics for STIs such as Chlamydia trachomatis, human papillomavirus, Neisseria gonorrhoeae, Trichomonas vaginalis, and Treponema pallidum. Key objectives included a review of current and emerging technologies, clinical and public health benefits, POC STI diagnostics in developing countries, regulatory considerations, and future areas of development. Key points of the meeting are as follows: (i) although some rapid pointof-care tests are affordable, sensitive, specific, easy to perform, and deliverable to those who need them for select sexually transmitted infections, implementation barriers exist at the device, patient, provider, and health system levels; (ii) further investment in research and development of point-of-care tests for sexually transmitted infections is needed, and new technologies can be used to improve diagnostic testing, test uptake, and treatment; (iii) efficient deployment of self-testing in supervised (ie, pharmacies, clinics, and so on) and/or unsupervised (ie, home, offices, and so on) settings could facilitate more screening and diagnosis that will reduce the burden of sexually transmitted infections; (iv) development of novel diagnostic technologies has outpaced the generation of guidance tools and documents issued by regulatory agencies; and (v) questions regarding quality management are emerging including the mechanism by which poor-performing diagnostics are removed from the market and quality assurance of self-testing is ensured.

Original languageEnglish (US)
Pages (from-to)211-218
Number of pages8
JournalSexually Transmitted Diseases
Volume44
Issue number4
DOIs
StatePublished - 2017
Externally publishedYes

ASJC Scopus subject areas

  • Dermatology
  • Public Health, Environmental and Occupational Health
  • Microbiology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Point-of-care sexually transmitted infection diagnostics: Proceedings of the STAR sexually transmitted infection-clinical trial group programmatic meeting'. Together they form a unique fingerprint.

Cite this